Carcinoma: all 6,719 studies
Page 53 of 68. Open to participants first (1,142), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE)WithdrawnNCT02014831Phase 2
- Safety and Efficacy Study of Pazopanib and MK 3475 in Advanced Renal Cell Carcinoma (RCC; KEYNOTE-018)CompletedNCT02014636Phase 1
- Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPCCompletedNCT02012062Phase 3
- Phase II Study of Maintenance Treatment of Nimotuzumab for Advanced Esophageal CarcinomaWithdrawnNCT02011594Phase 2
- The Role of microRNA-29b in the Oral Squamous Cell CarcinomaStatus unknownNCT02009852
- to Evaluate the Efficacy and Safety of MG4101(Ex Vivo Expanded Allogeneic NK Cell)CompletedNCT02008929Phase 2
- Ph 2 Trial of ADI PEG 20 Plus Concurrent Transarterial Chemoembolization (TACE) Vs TACE Alone in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT02006030Phase 2
- Anesthesia and Circulating Tumor Cells in Breast CancerCompletedNCT02005770Phase 4
- A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular CarcinomaWithdrawnNCT02004210Phase 3
- Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With YttriumCompletedNCT02003339Not applicable
- Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRICompletedNCT02002455Phase 2
- Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal CancerCompletedNCT02002312Phase 2
- Metabolomic Profiling in Renal Cell CarcinomaStatus unknownNCT02001493
- Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)CompletedNCT02000050Phase 2
- Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung CancerCompletedNCT01999673Phase 3
- A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCCStatus unknownNCT01997957Phase 4
- An Individualized Anti-Cancer Vaccine Study in Patients With HCCWithdrawnNCT01995227Phase 1/2
- EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma CellsStatus unknownNCT01993966
- MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical CancerTerminatedNCT01992861
- Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell CarcinomaStatus unknownNCT01987934
- HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck CancerCompletedNCT01984359Not applicable
- Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell CarcinomaCompletedNCT01982097
- Functional Imaging in the Assessment of mRCC Response to SunitinibWithdrawnNCT01977586Not applicable
- Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"Status unknownNCT01976468
- Pilot Study of Curcumin for Women With Obesity and High Risk for Breast CancerCompletedNCT01975363Not applicable
- Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular CarcinomaCompletedNCT01974661Phase 1
- Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional ChemotherapyCompletedNCT01973725Phase 2
- Non-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix.Status unknownNCT01973101Phase 2
- The Phase II Study of Icaritin in Patients With Advanced Hepatocellular CarcinomaCompletedNCT01972672Phase 2
- The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial CarcinomaStatus unknownNCT01968928
- 24hr Imaging Of HCC After EOVISTWithdrawnNCT01968629Early Phase 1
- TACE as an Adjuvant Therapy After Hepatectomy for HCCStatus unknownNCT01966133Phase 3
- Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular CarcinomaWithdrawnNCT01964235Phase 2
- Comparison Between Radiofrequency Ablation and Hypofractionated Proton Beam Radiation for Recurrent/Residual HCCCompletedNCT01963429Not applicable
- A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine GreenCompletedNCT01962649Early Phase 1
- Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving ChemoradiationCompletedNCT01958515
- FloSeal in CRS and HIPECCompletedNCT01957852
- PLA for HCC and Esophageal ca SerumStatus unknownNCT01957241
- Study of High-Dose Oral Vitamin D for the Prevention of Liver CancerWithdrawnNCT01956864Phase 1
- Adjuvant Radiation for High Risk Bladder CancerTerminatedNCT01954173Not applicable
- Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal CancerWithdrawnNCT01953952Phase 2
- The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular CarcinomaWithdrawnNCT01953406Phase 2
- NIMRAD (A Randomised Placebo-controlled Trial of Synchronous NIMorazole Versus RADiotherapy Alone in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Not Suitable for Synchronous Chemotherapy or Cetuximab)CompletedNCT01950689Phase 3
- Patient Preferences in Making Treatment Decisions in Patients With Stage I-IVA Oropharyngeal CancerTerminatedNCT01949740
- Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung CarcinomaStatus unknownNCT01947062Phase 3
- Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney CancerTerminatedNCT01943188Phase 1
- Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial CancerWithdrawnNCT01943058Phase 2
- A Non Interventional Study With Oxaliplatin Onkovis (Oxaliplatin) Utilized for the Treatment of CancerCompletedNCT01942200
- A Phase I, Open Label, Non Randomized, Multicenter, Dose Escalation Clinical Study to Investigate Safety and Tolerability of OPB(Otsuka Pharmaceutical Biwa)-111077 in Subjects With Advanced HCC(Hepatocellular Carcinoma)TerminatedNCT01942083Phase 1
- EVER/TMC Mutation as Marker of the Risk of Cutaneous Carcinoma in Immunosuppressed PatientsCompletedNCT01942005
- Role of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer PatientsCompletedNCT01941992Phase 2
- PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic CarcinomaCompletedNCT01939665Phase 1/2
- Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic CholangiocarcinomaCompletedNCT01938729Phase 1
- Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate CancerStatus unknownNCT01938339Not applicable
- Comparable Study of Different Radiation Dose in Esophageal CarcinomaStatus unknownNCT01937208Phase 3
- Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT01935973Phase 1
- Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck CancerCompletedNCT01935921Phase 1
- Urea Cream Treatment Sorafenib-Associated HSFR in HCCCompletedNCT01934829Phase 2
- Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by SorafenibCompletedNCT01933945
- Sorafenib in Liver Function Impaired Advanced Hepatocellular CarcinomaCompletedNCT01932385Phase 2/3
- Genetic Profile on Predicting Sensibility of Preoperative Chemoradiotherapy on Locally Advanced Rectal CarcinomaStatus unknownNCT01930942Phase 2
- Circulating Tumor Cells for Hepatocellular CarcinomaStatus unknownNCT01930383
- Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2TerminatedNCT01925118Phase 2
- Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular CarcinomaStatus unknownNCT01924624Not applicable
- DC Vaccine Combined With CIK Cells in Patients With Renal Cell CarcinomaStatus unknownNCT01924156Phase 1/2
- Preoperative Pain Control in Liver Surgery PatientsCompletedNCT01923948Not applicable
- In-Situ Therapeutic Cancer Vaccine for Refractory Liver CancerWithdrawnNCT01923233Phase 1/2
- A Phase 1 Dose Escalation Study of GC4419 in Combination With Chemoradiation for Squamous Cell Cancer of the Head & NeckCompletedNCT01921426Phase 1
- Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)CompletedNCT01915602Phase 2
- Refametinib(BAY86-9766) in RAS Mutant Hepatocellular Carcinoma (HCC)CompletedNCT01915589Phase 2
- Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal CarcinomaStatus unknownNCT01915134Phase 3
- Safety Study of Cord Blood-derived Cytokine-induced Killer Cells in Patients With Solid Tumor After Radical ResectionStatus unknownNCT01914263Phase 1
- Study of the Drug Ipilimumab for Metastatic Merkel Cell CarcinomaWithdrawnNCT01913691Phase 2
- Effectiveness and Safety of the Simultaneous Radiotherapy and Hyperthermia After Transarterial Chemoembolization in Hepatocellular Carcinoma Patients Combined With Portal Vein Tumor ThrombosisCompletedNCT01911000Phase 2
- Stereotactic Body Radiotherapy for Unresectable Hepatocellular CarcinomaCompletedNCT01910909Not applicable
- Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and SafetyCompletedNCT01908322
- Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial CarcinomaWithdrawnNCT01907308Phase 2
- Sorafenib Chemoembolization Evaluation Controlled TrialCompletedNCT01906216Phase 3
- Nanocytology Test to Evaluate Skin Cancer in High Risk PatientsCompletedNCT01905891Not applicable
- Study of Hepatocellular Carcinoma in Cirrhotic PatientsCompletedNCT01904942
- Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Head and Neck Basal Cell CarcinomasStatus unknownNCT01903239Not applicable
- Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular InvasionCompletedNCT01901692Phase 2/3
- Laparoscopy-Assisted Surgery for Carcinoma of the Low RectumStatus unknownNCT01899547Not applicable
- Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCCCompletedNCT01897610Phase 2
- A Safety, Tolerability, and Pharmacokinetics Study of Onartuzumab as Single Agent or in Combination With Sorafenib in Participants With Advanced Hepatocellular CarcinomaCompletedNCT01897038Phase 1
- Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With CancerCompletedNCT01896778Not applicable
- Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative ChemotherapyCompletedNCT01894451Early Phase 1
- Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA ReplicationStatus unknownNCT01894269Phase 4
- VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated PathwayStatus unknownNCT01892072
- Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular CarcinomaStatus unknownNCT01891539
- Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.CompletedNCT01890291
- Azacitidine and Entinostat in Treating Patients With Newly Diagnosed Stage IA-IIIA Non-Small Lung Cancer Undergoing SurgeryTerminatedNCT01886573Phase 1
- Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNNCompletedNCT01884259Phase 2
- Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder CarcinomaCompletedNCT01878188Phase 1
- Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx CarcinomaCompletedNCT01874587Phase 3
- Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast CancerCompletedNCT01874184Not applicable
- Determination of Cetuximab Versus Cisplatin Early and Late Toxicity Events in HPV+ OPSCCStatus unknownNCT01874171Phase 3
- Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular CarcinomaTerminatedNCT01872988Phase 3
- Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT01872962Phase 3
- Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel/Carboplatin vs. Paclitaxel /Carboplatin in Stage Ⅱ B and IIIA Squamous Cell Carcinoma of the LungStatus unknownNCT01872403Phase 2